Publications

  • Truong TH, Benner EA, Hagen KM, Temiz NA, Kerkvliet CP, Wang Y, Cortes-Sanchez E, Yang CH, Trousdell MC, Pengo T, Guillen KP, Welm BE, Dos Santos CO, Telang S, Lange CA, Ostrander JH. PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer. Oncogene. 2021 Jun 8.

  • Kerkvliet CP, Truong TH, Ostrander JH, & Lange CA (2021). Stress sensing within the breast tumor microenvironment: How glucocorticoid receptors live in the moment. Essays Biochem. 2021 Jun 16

  • Dwyer AR, Truong TH, Ostrander JH, Lange CA. Steroid Receptors as MAPK Signaling Sensors in Breast Cancer: Let the Fates Decide. J Mol Endocrinol. 2020 Mar 1.

  • Truong TH, Lange CA, Ostrander JH. Targeting steroid receptor co-activators to inhibit breast cancer stem cells. Oncoscience. 2018 Aug 28;5(11-12):281-282.

  • Regan Anderson TM, Ma S, Perez Kerkvliet C, Peng Y, Helle TM, Krutilina RI, Raj GV, Cidlowski JA, Ostrander JH, Schwertfeger KL, Seagroves TN, Lange CA. Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis. Mol Cancer Res. 2018 Nov;16(11):1761-1772.

  • Truong TH, Hu H, Temiz NA, Hagen KM, Girard BJ, Brady NJ, Schwertfeger KL, Lange CA, Ostrander JH. Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes. Mol Cancer Res. 2018 Apr;16(4):707-719.

  • Girard BJ, Knutson TP, Kuker B, McDowell L, Schwertfeger KL, Ostrander JH. Cytoplasmic Localization of Proline, Glutamic Acid, Leucine-rich Protein 1 (PELP1) Induces Breast Epithelial Cell Migration through Up-regulation of Inhibitor of κB Kinase ϵ and Inflammatory Cross-talk with Macrophages. J Biol Chem. 2017 Jan 6;292(1):339-350.

  • Leehy KA, Regan Anderson TM, Daniel AR, Lange CA, Ostrander JH. Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer. J Mol Endocrinol. 2016 Apr;56(3):R99-R114.

  • Girard BJ, Regan-Anderson TM, Lem S, Nicely J, Seewaldt VL, Ostrander JH. Cytoplasmic PELP1 and estrogen-related receptor gamma protect human mammary epithelial cells from tamoxifen-induced cell death. PLoS One. 2015 Mar 19;10(3).

  • Daniel AR, Gaviglio AL, Knutson TP, Ostrander JH, Ravindranathan P, Peng Y, Raj GV, Yee D, Lange CA. Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene. 2014 Jan 27. 24469035. PMCID: In progress

  • Girard BJ, Daniel AR, Lange CA, Ostrander JH. PELP1: A review of PELP1 interactions, signaling, and biology. Mol Cell Endocrinol. 2014 Jan 25;382(1):642-51.

  • Ostrander JH*, D’Amato NC*, Cardiff RD, Young LJ, Simin K, Bachelder RE, Ibarra-Drendall C, Bowie ML, Yu D, Delrow J, Dawson A, Yee LD, Mrózek K, Clay T, Osada T, Troch MM, Seewaldt VL. Phenotypic Plasticity in an Aggressive Triple-Negative Human Breast Cancer: Human biology is recapitulated by a novel model system. PLoS One. 2012;7(9) *Authors contributed equally to this manuscript.

  • Lofgren KA, Ostrander JH, Housa D, Hubbard GK, Locatelli A, Bliss RL, Schwertfeger KL, Lange CA. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK. Breast Cancer Res. 2011 Sep 17;13(5):R89.